Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BA enters its October 21 earnings print with the options optimism flagged last week now fading and the Street busy revising targets lower, a setup that looks more cautious than the bullish call-skew suggested a week ago.
The options shift is the sharpest change from last week's note. The put/call ratio has climbed back to 0.816, now sitting just below its 20-day average of 0.829 and essentially neutral after spending the prior week more than two standard deviations below that average. The pronounced call tilt has unwound. The stock itself closed at $186.49, down 1.6% on Tuesday and off 1.8% for the week, extending the month's decline to more than 11%. The gap between where the stock trades and the Street's mean target of $269 remains wide, but options traders are no longer leaning hard into it.
Analyst activity has turned decisively cautious in the days immediately before the print. Bernstein cut its target to $278 from $298 on Monday, maintaining Outperform, and TD Cowen trimmed to $240 from $250 on Thursday, also keeping Buy. Barclays initiated coverage on Thursday with Overweight and a $300 target, providing some ballast on the bullish side. The broader picture is one of analysts who remain positive on direction but are marking down near-term expectations: most targets still sit well above $186, and EPS momentum scores rank in the 94th and 97th percentile on 30-day and 90-day bases respectively, meaning forward estimates have been moving up even as targets edge down. The bull case rests on a $715 billion backlog, Q2 free cash flow of $631 million, and rising deliveries. The bear case is harder to dismiss: return on capital is still negative at -7.08% and NOPAT remains in the red over the last twelve months, so growth has not yet converted into durable profitability.
Short positioning is a sideshow. Short interest is 2.0% of free float, up roughly 3% on the week after dipping on Tuesday, consistent with the low and range-bound levels flagged in the previous note. Borrow availability is extraordinarily loose at more than 4,479% of shares short, meaning the lending pool holds vastly more shares than are currently borrowed. Cost to borrow moved up 47% on the week to 0.40%, but that brings it back only to where it was at the start of October. There is no meaningful squeeze pressure, and the short score of 31.5 sits comfortably in the lower half of the universe.
Capital Research and Management stands out in the institutional register. Its most recent disclosure shows a purchase of nearly 9.9 million shares, the largest change of any top holder in the snapshot. BlackRock and FMR both added modestly. No 13D activists are on the register. The activist disclosure note applies: these positions are as-last-reported and stakes can drift below 5% without a further filing.
The last earnings print, in late July, produced a muted one-day reaction of just 0.3% but a five-day gain of more than 8%. That pattern, a small initial move followed by a larger directional move over the following week, is what to watch when the Q3 numbers land on October 21.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
